Stocks · Healthcare · Medical - Care Facilities
Universal Health Services, Inc. UHS
$175.72 +0.37% Close, Oct 2, 2026 · NYSE · Market cap $10.64B
High qualityInexpensive vs sectorLow risk
Next earnings report: Oct 26, 2026
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- The shares trade at 7.2× trailing earnings, lower than 90% of the company's own readings over the past five years.
- The diluted share count fell 7.8% in a year, mainly through buybacks.
- The stock is in a downtrend: below its 200-day average, with the 50-day average below the 200-day.
PromtFinance scores
Each score is a percentile within the Healthcare sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 5, 2026.
Growth47Neutral
How fast revenue, earnings and cash flow are growing.
- Revenue growth (TTM, YoY)Top 47%
- EPS growth (TTM, YoY)Top 35%
- FCF growth (TTM, YoY)Bottom 34%
- Revenue growth, 3-year CAGRBottom 46%
- Revenue growth accelerationBottom 49%
Quality80Strong
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalTop 12%
- Gross marginTop 19%
- Operating marginTop 24%
- Cash conversion (OCF / net income)Bottom 30%
- Accruals (lower is better)Bottom 22%
- Net debt / EBITDA (lower is better)Bottom 41%
- Interest coverTop 14%
Value99Exceptional
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldTop 2%
- Free-cash-flow yieldTop 11%
- EBITDA / enterprise valueTop 3%
- Sales / enterprise valueTop 7%
- P/E vs own 5-year history (lower is better)Top 22%
Momentum35Weak
Strength and persistence of the price trend, including versus the S&P 500.
- 12-month return excluding last monthBottom 24%
- 6-month returnBottom 43%
- 1-year return vs S&P 500Bottom 33%
- Distance from 52-week highTop 45%
- Trend checklist (0–4)Bottom 38%
Revisions17Very weak
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersTop 44%
- Consecutive EPS beatsTop 35%
- Share of analysts rating BuyBottom 7%
- Upside to consensus price targetBottom 18%
Stability87Strong
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Top 9%
- Maximum drawdown, 3 yearsTop 16%
- Beta vs S&P 500 (lower is better)Top 16%
- Net debt / EBITDA (lower is better)Bottom 41%
What changed
Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).
| Measure | Before | Now | |
|---|---|---|---|
| Revenue growth (YoY) | 10.4% | 10.0% | ↓ |
| EPS growth (YoY) | 33.7% | 28.4% | ↓ |
| Gross margin | 90.2% | 90.7% | ↑ |
| Operating margin | 11.0% | 11.4% | ↑ |
| FCF margin | 5.5% | 4.6% | ↓ |
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Revenue growth (TTM, YoY) | 10.0% | 10.4% | ↓ | Top 47% |
| EPS growth (TTM, YoY) | 28.4% | 33.7% | ↓ | Top 35% |
| Gross margin | 90.7% | 90.2% | ↑ | Top 19% |
| Operating margin | 11.4% | 11.0% | ↑ | Top 24% |
| Net margin | 8.4% | 7.7% | ↑ | — |
| Free-cash-flow margin | 4.6% | 5.5% | ↓ | — |
| Return on invested capital | 11.7% | — | Top 12% | |
| Revenue growth, 3-year CAGR | 9.0% | — | Bottom 46% |
Quality of earnings and balance sheet
- Cash conversion (OCF / net income)Above 1× means profits are backed by cash.
- 1.18×
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- -1.7%
- Stock-based compensation / revenueA cost to shareholders through dilution.
- 0.3%
- Receivables growth vs revenue growthReceivables growing much faster than sales can be a warning.
- +11.6 pp
- Net debt / EBITDABelow 1× is conservative; above 3× is high leverage.
- 1.82×
- Interest cover (operating income / interest)How many times operating profit covers interest.
- 13.2×
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 0.47%
- Net buyback yield (TTM)
- 9.93%
- Shareholder yield
- 10.40%
- Share count change, 1 year
- -7.8%
- Share count change, 3-year CAGR
- -5.4%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Jun 30, 2026 (filed Aug 7, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 2
- Beats in the last 8 reports
- 7 of 8
- Average EPS surprise, last 4
- +6.5%
- Average 2-day reaction, last 8
- -0.2%
- Positive 20 days after report
- 4 of 8
Analysts
- Consensus price target
- $193.00
- Target vs current price
- +9.8%
- Analysts with a rating
- 44
- Share rating Buy or Strong Buy
- 39%
- Consensus rating
- Hold
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Jul 27, 2026 | +0.7% | +2.3% | +8.1% | +13.8% | — |
| Apr 27, 2026 | +3.9% | +3.0% | -4.2% | -9.5% | -14.3% |
| Feb 25, 2026 | -0.7% | +0.3% | -10.9% | -19.2% | -28.6% |
| Oct 27, 2025 | +22.1% | +1.6% | +3.0% | +10.1% | -2.4% |
| Jul 28, 2025 | +8.7% | -0.4% | +4.7% | +19.3% | +33.2% |
| Apr 28, 2025 | +11.3% | +0.7% | +4.1% | +8.5% | -4.0% |
| Feb 26, 2025 | +16.9% | -4.7% | -8.3% | -1.6% | +0.6% |
| Oct 24, 2024 | +1.6% | -4.1% | -11.4% | -15.6% | -20.1% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Jul 27, 2026 | $5.98 | $5.94 | +0.7% | $4.64B |
| Apr 27, 2026 | $5.62 | $5.41 | +3.9% | $4.50B |
| Feb 25, 2026 | $5.88 | $5.92 | -0.7% | $4.49B |
| Oct 27, 2025 | $5.69 | $4.66 | +22.1% | $4.50B |
| Jul 28, 2025 | $5.35 | $4.92 | +8.7% | $4.28B |
| Apr 28, 2025 | $4.84 | $4.35 | +11.3% | $4.10B |
| Feb 26, 2025 | $4.92 | $4.21 | +16.9% | $4.11B |
| Oct 24, 2024 | $3.71 | $3.65 | +1.6% | $3.96B |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| P/E (trailing) | 7.2× | 11.5× | 10th | Top 2% |
| P/E (forward) | 7.8× | — | — | — |
| EV / EBITDA | 5.6× | — | — | Top 3% |
| EV / Sales | 0.87× | — | — | Top 7% |
| Free-cash-flow yield | 7.77% | — | — | Top 11% |
| Earnings yield | 13.87% | — | — | Top 2% |
P/E over the past five years
Range 7.1× – 16.2× since Jun 30, 2021. Each point: price on the filing date divided by trailing-twelve-month EPS known then.
What moved the stock over the past year
- Price return, 1 year
- -13.7%
- Earnings per share growth (TTM)
- +28.4%
- Change in P/E multiple
- -21.5%
Most of the move came from earnings growth.
Technical state
Trend checklist
- ✗ Price above 20-day average
- ✓ Price above 50-day average
- ✗ Price above 200-day average
- ✗ 50-day average above 200-day
- ✗ MACD histogram positive
Trend quality
- Days above the 50-day average
- 50
- Days above the 200-day average
- 0
- 50-day average slope (20 days)
- +6.0%
- 200-day average slope (20 days)
- -3.0%
- Distance from 50-day average
- +1.8%
- Distance from 200-day average
- -2.8%
- RSI (14)
- 51.6
- Relative volume
- 0.76×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 29.9%
- Volatility vs own 5-year history
- 50th percentile · Normal for this stock
- Beta vs S&P 500 (2 years, weekly)
- 0.51
- Correlation with S&P 500
- 0.24
- Current drawdown from 1-year high
- -28.0%
- Maximum drawdown, 3 years
- -42.2%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| Aug 3, 2021 | Sep 27, 2022 | -45.3% | 290 days | 338 days (Feb 1, 2024) |
| Nov 26, 2025 | Jun 18, 2026 | -42.2% | 139 days | Not yet recovered |
| Sep 24, 2024 | Jul 28, 2025 | -35.8% | 209 days | 85 days (Nov 25, 2025) |
| Mar 28, 2024 | Apr 18, 2024 | -15.8% | 14 days | 29 days (May 30, 2024) |
| Jan 7, 2021 | Jan 29, 2021 | -12.5% | 15 days | 53 days (Apr 16, 2021) |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $10.64B
- P/E (TTM)
- 7.2
- EPS, diluted (TTM)
- $24.38
- Revenue (TTM)
- $18.11B
- Dividend yield
- 0.46%
- 52-week range
- $140.08 – $246.33
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | $12.64B | $13.40B | $14.28B | $15.83B | $17.36B |
| Gross profit | $11.21B | $11.93B | $12.75B | $14.24B | $15.71B |
| Operating income | $1.36B | $1.00B | $1.18B | $1.68B | $1.99B |
| Net income | $991.6M | $675.6M | $717.8M | $1.14B | $1.49B |
| EPS (diluted) | $11.82 | $9.14 | $10.23 | $16.82 | $23.10 |
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $3.96B | $4.11B | $4.10B | $4.28B | $4.50B | $4.49B | $4.50B | $4.64B |
| Net income | $258.7M | $332.4M | $316.7M | $353.2M | $373.0M | $445.9M | $348.7M | $358.4M |
| EPS (diluted) | $3.80 | $4.96 | $4.80 | $5.43 | $5.74 | $7.01 | $5.65 | $5.98 |
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Operating cash flow | $883.7M | $996.0M | $1.27B | $2.07B | $1.86B |
| Capital expenditure | -$855.7M | -$734.0M | -$743.1M | -$943.8M | -$1.02B |
| Free cash flow | $28.0M | $262.0M | $524.7M | $1.12B | $849.2M |
| Dividends paid | -$65.9M | -$58.4M | -$55.5M | -$53.3M | -$51.3M |
| Net share buybacks | -$1.21B | -$818.9M | -$533.7M | -$655.7M | -$951.2M |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $138.8M
- Total assets
- $15.94B
- Total liabilities
- $8.28B
- Total debt
- $5.26B
- Net debt
- $5.12B
- Shareholders’ equity
- $7.51B
As of Jun 30, 2026 (filed Aug 7, 2026).
Dividends
| Ex-date | Amount | Paid |
|---|---|---|
| Sep 1, 2026 | $0.20 | Sep 15, 2026 |
| Jun 8, 2026 | $0.20 | Jun 18, 2026 |
| Mar 2, 2026 | $0.20 | Mar 16, 2026 |
| Dec 1, 2025 | $0.20 | Dec 15, 2025 |
| Sep 2, 2025 | $0.20 | Sep 16, 2025 |
| Jun 2, 2025 | $0.20 | Jun 16, 2025 |
| Mar 3, 2025 | $0.20 | Mar 17, 2025 |
| Dec 3, 2024 | $0.20 | Dec 17, 2024 |
Short interest
- Shares sold short
- 2,720,468
- Days to cover
- 4.16
- Change vs previous report
- +5.7%
FINRA short interest, settlement date Sep 15, 2026.
Stock splits
- Dec 16, 2009
- 2-for-1
- Jun 4, 2001
- 2-for-1
- May 20, 1996
- 2-for-1
- Jul 5, 1983
- 2-for-1